-
Article
Open AccessSelf-reported late effects and long-term follow-up care among 1889 long-term Norwegian Childhood, Adolescent, and Young Adult Cancer Survivors (the NOR-CAYACS study)
The majority of childhood, adolescent, and young adult cancer survivors (CAYACS) are at risk of late effects but may not receive long-term follow-up care for these. Here, we investigated (1) self-reported late...
-
Article
Lifestyles of cancer survivors attending an inpatient educational program—a cross-sectional study
Cancer survivors have increased risk for adverse health effects, but the risk can be reduced by adopting a healthy lifestyle. Knowledge of lifestyle in terms of physical activity (PA), diet (intake of fruit an...
-
Article
Open AccessIncreased stomach cancer risk following radiotherapy for testicular cancer
Abdominal radiotherapy for testicular cancer (TC) increases risk for second stomach cancer, although data on the radiation dose–response relationship are sparse.
-
Article
Open AccessSecond cancer risk and mortality in men treated with radiotherapy for stage I seminoma
Patients with stage I testicular seminoma are typically diagnosed at a young age and treatment is associated with low relapse and mortality rates. The long-term risks of adjuvant radiotherapy in this patient g...
-
Article
Open AccessSperm counts and endocrinological markers of spermatogenesis in long-term survivors of testicular cancer
The objective of this study was to assess markers of spermatogenesis in long-term survivors of testicular cancer (TC) according to treatment, and to explore correlations between the markers and associations wi...
-
Article
Open AccessWhy do patients with radiation-induced sarcomas have a poor sarcoma-related survival?
This study aims to provide reasons for the poor sarcoma-related survival in patients with radiation-induced sarcoma (RIS).
-
Article
Fatigue in hormone-naïve prostate cancer patients treated with radical prostatectomy or definitive radiotherapy
Chronic fatigue (CF) is a distressing symptom that follows cancer treatment; however, it has rarely been studied in hormone-naïve prostate cancer survivors after radical prostatectomy (RP) or definitive radiot...
-
Article
Alterations of gene expression in blood cells associated with chronic fatigue in breast cancer survivors
Fatigue is one of the most frequent complaints among breast cancer survivors. However, mechanisms underlying persisting fatigue after end of treatment are poorly understood. To explore whether biological proce...
-
Article
Definitive radiotherapy with adjuvant long-term antiandrogen treatment for locally advanced prostate cancer: health-related quality of life and hormonal changes
We assessed self-reported health-related quality of life (HRQoL) and longitudinal changes in sex hormones among 86 prostate cancer (PCa) patients without distant metastases 5 years after radiotherapy (RT) comb...
-
Article
Open AccessValvular dysfunction and left ventricular changes in Hodgkin's lymphoma survivors. A longitudinal study
Hodgkin's lymphoma survivors (HLSs) have an elevated risk for cardiovascular diseases that appear several years after radiotherapy. This study examined the time-dependent development and evolution of valvular ...
-
Article
Spättoxizität nach Hodentumortherapie unter besonderer Berücksichtigung sexueller Störungen
Dank Cisplatin-basierter Chemotherapie erreicht die Kurationsrate von Patienten mit Hodenkrebs 90%. Chemotherapie ist, wie auch die Radiotherapie, mit Langzeitkomplikationen wie Herz-Kreislauf-Erkrankungen, de...
-
Article
Open AccessGonadal function in male patients after treatment for malignant lymphomas, with emphasis on chemotherapy
Gonadal function was assessed in male lymphoma survivors based on serum hormone levels (LH, FSH, testosterone, SHBG), and was related to treatment, age and observation time. Male patients ⩽50 years at diagnosi...
-
Article
Predicted cardiovascular mortality and reported cardiovascular morbidity in testicular cancer survivors
We examined if testicular cancer (TC) treatment is associated with any risk for cardiovascular morbidity or predicted mortality according to the SCORE model, in which a 10-year future risk of ≥5% for developin...
-
Article
Open AccessPost-treatment parenthood in Hodgkin's lymphoma survivors
Attempted and achieved post-treatment parenthood, with or without use of assisted reproduction techniques (ARTs), was assessed in Hodgkin's lymphoma survivors treated from 1971–1998, aged below 50 (females) or...
-
Article
Treatment-related differences in cardiovascular risk factors in long-term survivors of testicular cancer
Treatment in testicular cancer survivors (TCSs) may be followed by cardiovascular disorders. We have examined whether today’s three treatment modalities are assicated with a biochemical cardiovascular risk pro...
-
Article
Open AccessLate recurrences of germ cell malignancies: a population-based experience over three decades
The purpose of this study was to explore the incidence of late relapse in patients with malignant germ cell tumour (MGCT) in a population-based series, with emphasis on the mode of detection, survival, and the...
-
Article
Open AccessIntensive induction chemotherapy with C-BOP/BEP for intermediate- and poor-risk metastatic germ cell tumours (EORTC trial 30948)
New chemotherapy regimens are continuously explored in patients with high-risk malignant germ cell tumours (MGCTs). This multicentre phase II trial assessed the efficacy and toxicity of C-BOP/BEP chemotherapy ...
-
Article
Open AccessAdjuvant bleomycin, vincristine and cisplatin (BOP) for high-risk stage I non-seminomatous germ cell tumours: a prospective trial (MRC TE17)
Adjuvant BEP (bleomycin, etoposide, cisplatin) is effective treatment for high-risk clinical stage I (HRCS1) non-seminomatous germ cell tumours (NSGCT), but the known toxicities of etoposide, and the expansion...
-
Article
Open AccessSomatic mutations of KIT in familial testicular germ cell tumours
Somatic mutations of the KIT gene have been reported in mast cell diseases and gastrointestinal stromal tumours. Recently, they have also been found in mediastinal and testicular germ cell tumours (TGCTs), par...
-
Article
Open AccessIncreased mortality rates in young and middle-aged patients with malignant germ cell tumours
Cisplatin-based chemotherapy of malignant germ cell tumours (MGCT) has been reported to increase the risk of cardiovascular morbidity. A high incidence of second nongerm cell malignancies is well documented in...
